Matinas BioPharma Holdings MTNB Balance Sheet (2013-2026)

NYSE MTNB
$2.86 +0.33 (+12.85%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Matinas BioPharma Holdings Quarterly Balance Sheet

Periods 54 quarters
Latest Jun 2026

Matinas BioPharma Holdings reported total assets of $3.41M and total liabilities of $1.61M for the quarter ended Jun 2026, down 70.1% year over year. This balance sheet covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
24.92M21.03M19.33M10.40M11.18M6.83M5.74M9.74M6.41M4.79M1.07M4.22M10.29M7.28M6.92M6.53M5.43M4.00M2.40M0.76M
Short-term InvestmentsInvestments (Current)
28.91M28.59M24.54M28.10M21.88M21.93M19.12M12.77M11.81M8.97M7.04M10.10M0.50M
Cash & Current Investments
53.83M49.62M43.87M38.50M33.05M28.76M24.86M22.51M18.22M13.76M8.11M14.31M10.79M7.28M6.92M6.53M5.43M4.00M2.40M0.76M
Receivables - NetNet Receivables
0.98M
Receivables - OtherOther Receivables
4.55M
Receivables
0.98M
Prepaid Assets
2.60M1.32M1.20M3.37M4.00M5.72M3.30M1.44M1.72M1.74M2.13M0.92M0.90M0.69M0.57M0.69M0.17M0.03M0.37M0.33M
Current Assets
56.48M50.99M45.12M41.92M37.10M34.53M28.21M24.00M19.99M15.54M10.29M15.29M11.74M8.03M7.55M7.27M5.65M4.08M2.81M1.14M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
1.57M1.54M2.01M1.98M2.14M2.09M2.00M2.10M2.02M1.92M1.83M1.74M1.65M0.47M0.45M0.16M0.16M0.14M0.14M
Long-Term Investments
0.07M0.07M
Goodwill
1.34M1.34M1.34M1.34M1.34M1.34M1.34M1.34M1.34M1.34M1.34M1.34M1.34M
Intangibles
3.02M3.02M3.02M3.02M3.02M3.02M3.02M3.02M3.02M3.02M3.02M3.02M3.02M2.26M2.26M2.26M2.26M2.26M2.26M2.26M
Goodwill & Intangibles
4.35M4.35M4.35M4.35M4.35M4.35M4.35M4.35M4.35M4.35M4.35M4.35M4.35M2.26M2.26M2.26M2.26M2.26M2.26M2.26M
Other Non-Current Assets
0.30M0.20M0.30M0.30M0.30M0.20M0.25M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.20M
Non-Current Assets
10.50M10.33M10.67M10.49M10.45M10.29M10.06M10.03M9.80M9.56M9.32M9.08M8.84M4.62M4.49M4.16M4.04M3.13M3.06M2.27M
Assets
66.98M61.33M55.78M52.42M47.55M44.82M38.26M34.02M29.79M25.10M19.61M24.36M20.58M12.64M12.04M11.42M9.70M7.21M5.87M3.41M
Liabilities
Current Liabilities
Accounts Payables
0.66M0.94M1.35M0.50M0.66M0.62M0.52M1.37M1.76M0.51M0.47M0.24M0.35M0.10M0.28M0.17M0.08M0.32M0.71M0.84M
Notes Payables
Dividends payables
Payables
0.66M0.94M1.35M0.50M0.66M0.62M0.52M1.37M1.76M0.51M0.47M0.24M0.35M0.10M0.28M0.17M0.08M0.32M0.71M0.84M
Accumulated Expenses
2.89M2.85M1.84M4.29M3.70M3.10M0.79M1.37M1.76M1.45M0.84M1.44M1.04M1.80M1.18M0.80M0.56M0.45M0.69M0.50M
Other Accumulated Expenses
1.23M0.90M0.70M0.44M0.19M0.09M1.51M0.92M0.48M0.12M
Current Leases
0.02M0.02M0.02M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M
Current Deferred Revenue
Curent Deferred Tax LiabilityCurent Deferred Tax
Total Current Liabilities
4.10M4.35M3.77M5.38M4.90M4.29M1.90M2.59M3.23M2.62M2.00M2.39M2.12M2.67M2.25M1.78M1.50M1.46M2.13M1.35M
Non-Current Liabilities
Capital Leases
0.01M0.00M0.02M0.02M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.34M0.26M0.26M0.26M0.26M0.26M0.26M0.26M
Operating Leases
4.28M4.14M3.99M3.84M3.68M3.53M3.38M3.22M3.05M2.88M2.70M2.51M2.32M2.12M1.91M1.70M1.47M0.65M0.46M
Other Non-Current Liabilities
1.20M0.90M0.67M0.44M0.19M0.09M1.33M
Total Non-Current Liabilities
4.63M4.48M4.33M4.18M4.03M3.90M3.74M3.58M3.41M3.24M3.05M2.87M2.67M2.38M3.51M1.97M1.74M0.92M0.73M0.26M
Total Liabilities
8.73M8.83M8.10M9.57M8.93M8.18M5.64M6.17M6.64M5.86M5.05M5.26M4.80M5.05M5.76M3.75M3.23M2.38M2.85M1.61M
Shareholder's Equity
Total Debt
Common Equity
58.25M52.49M47.68M42.85M38.62M36.64M32.62M27.85M23.15M19.25M14.56M19.10M15.78M7.59M6.27M7.67M6.46M4.83M3.02M1.80M
Liabilities and Shareholders Equity
66.98M61.33M55.78M52.42M47.55M44.82M38.26M34.02M29.79M25.10M19.61M24.36M20.58M12.64M12.04M11.42M9.70M7.21M5.87M3.41M
Retained Earnings
-124.93M-131.63M-137.61M-143.54M-149.00M-152.63M-158.14M-164.20M-170.26M-175.57M-181.40M-187.12M-191.39M-199.82M-201.48M-206.72M-208.88M-210.79M-212.71M-214.03M
Preferred Shares

Matinas BioPharma Holdings Balance Sheet API

Pull Matinas BioPharma Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MTNB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY